Bringing the fundamentals into focus…
Back to Aquestive Therapeutics, Inc.
How Aquestive Therapeutics, Inc. stacks up
AQST · against 447 other Healthcare companies of similar size
Profitability
12/ 100
Near the bottom of its peers.
Ranked #390 of 448 · scores higher than 12% of peers
Bars: peers in each 10-point band of the profitability score46 peers with a profitability score of 10–19, including AQST · Click a bar to see the companies
Why profitability scores 12?
Weighted metrics compared with all Healthcare companies.Mainly because of its return on assets and operating margin, which are weaker than most Healthcare peers.
- a lower return on assets: weaker than 95% of peers. Return on assets: -59.2% vs peer median 1.7%
- a thinner operating margin: weaker than 87% of peers. Operating margin: -97.5% vs peer median 7.1%
- Return on invested capital is not reported, so it is left out of the score.
Metric by metric
Position: dot = AQST, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | AQST | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 419 reported | Not reported | 1.9% | — | — | 33% |
| Operating marginHigher is better · 420 reported | -97.5% | 4.8% | 13% | 33% | |
| Return on assetsHigher is better · 444 reported | -59.2% | 0.9% | 6% | 33% | |
| Return on equityHigher is better · 424 reported | Not reported | 0.9% | — | — | Context only |
| Gross marginHigher is better · 464 reported | 67.0% | 40.4% | 78% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by profitability score
Top 5 and the companies ranked around AQST| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 595M USD | 99 | 97 | |
| 1 | 433M USD | 99 | 81 | |
| 1 | 578M USD | 99 | 73 | |
| 1 | 914M USD | 99 | 81 | |
| 1 | 609M USD | 99 | 91 | |
| 385 | 534M USD | 13 | 32 | |
| 385 | 5.1B MXN (≈$274M) | 13 | 48 | |
| 385 | 673M USD | 13 | 35 | |
| 390 | 337M USD | 12 | 33 | |
| 390 | 487M USD | 12 | 24 | |
| 390 | 319M USD | 12 | 28 | |
| 390 | 421M USD | 12 | 52 | |
| 390 | 388M USD | 12 | 36 | |
| 395 | 539M USD | 11 | 33 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score